Passage Bio, Inc.
Passage Bio, Inc. (PASG) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
pasg · stock forecast · 11 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$15.00
Consensus
$10.00
+82.8% upside
Low
$7.00
Median: $8 · Last Close: $5.47
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$10.00
82.8% upside
High Target
$15
174.2%
Low Target
$7
28.0%
Current Price
$5.47
as of today
Based on analyst price targets, the PASG stock price prediction for the next 12 months ranges from $7 to $15. The consensus PASG price forecast of $10.00 implies 82.8% upside from the current price of $5.47.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $5.72 | ↑ 4.48% |
1-day model range: $5.67–$5.77. Peak: $5.77 (+4.48%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PASG · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-21 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-04-21 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2026-04-21 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2026-04-21 | Chardan Capital | Downgrade ↓ | Buy→Neutral |
| 2026-03-04 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-11-12 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-14 | Guggenheim | Maintains | Buy→Buy |
| 2025-08-14 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-08-13 | Wedbush | Maintains | Outperform→Outperform |
| 2025-06-24 | Chardan Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Passage Bio, Inc. (PASG) stock. Of the recent 40 rating actions, 2 were upgrades and 7 were downgrades. 11 analysts currently cover PASG.
Analyst Recommendation Trends
PASG analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 93.7% YoY
Revenue Next Year
$45M
↑ 2150.6% YoY
EPS This Year
$-9.21
EPS Next Year
$-7.84
↓ 14.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast PASG EPS of $-9.21 for the current fiscal year, based on estimates from 3 analysts. The PASG revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PASG stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PASG price target is $10.00 (+82.8% upside), with an analyst consensus of Buy.
The PASG short-term stock prediction for tomorrow is $5.72 (+4.48%).
Passage Bio, Inc. trades on NASDAQ under the ticker PASG. The PASG stock outlook for 2027 is broadly positive, supported by a Buy consensus among 55% of covering analysts.
Frequently asked questions
PASG forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month PASG price target is $10.00, with a high forecast of $15.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +82.8% potential upside from the current price of $5.47.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.